Nd: YAG laser rescue of sulcus-placed glaucoma drainage device tube occlusion: a two-case series.

BMC OphthalmolSep 3, 2026 (epub)
Case ReportOphthalmologyOpen access

Md Iftekher Iqbal, Fariah Osman

✦ AI-curated · Sources linked

Case in brief

Two cases of postoperative tube obstruction in patients with Aurolab Aqueous Drainage Implants (AADI) were treated with Nd: YAG laser. The first case involved an 11-year-old girl with iris obstruction, successfully treated with laser iridotomy, resulting in stable intraocular pressure at 12 mmHg after 7 months. The second case, a 38-year-old man, experienced vitreous obstruction, where laser vitreolysis initially reduced intraocular pressure but later led to complications requiring implant explantation.

Diagnostic / clinical pearl

Nd: YAG laser can be an effective first-line treatment for tube obstructions in glaucoma drainage devices, particularly in high-risk patients, potentially avoiding the need for surgical revision.

Why it matters

This case highlights the utility of Nd: YAG laser in managing complications of glaucoma drainage devices, especially in resource-limited settings, while emphasizing the importance of monitoring for potential long-term complications.

Source

Published in BMC Ophthalmol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.